摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-{6-[(4-hydroxymethyl)-piperidino]-2-naphthyl}-1-ethanone | 214460-98-7

中文名称
——
中文别名
——
英文名称
1-{6-[(4-hydroxymethyl)-piperidino]-2-naphthyl}-1-ethanone
英文别名
1-[6-[4-(Hydroxymethyl)piperidin-1-yl]naphthalen-2-yl]ethanone
1-{6-[(4-hydroxymethyl)-piperidino]-2-naphthyl}-1-ethanone化学式
CAS
214460-98-7
化学式
C18H21NO2
mdl
——
分子量
283.37
InChiKey
LVJHZRBEPBESKZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    484.4±15.0 °C(Predicted)
  • 密度:
    1.152±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    40.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Methods for binding agents to b-amyloid plaques
    申请人:Barrio R. Jorge
    公开号:US20070053831A1
    公开(公告)日:2007-03-08
    A method for labeling structures, such as β-amyloid plaques and neurofibrillary tangles, in vivo or in vitro, is provided and comprises contacting brain tissue with one or more compounds, preferably radiolabeled for detection by positron emission tomography (PET).
    提供了一种用于在体内或体外标记结构(如β-淀粉样斑块和神经原纤维缠结)的方法,包括将大脑组织与一个或多个化合物接触,最好是用正电子发射断层扫描(PET)检测的放射性标记。
  • Compositions for labeling beta-amyloid plaques and neurofibrillary tangles
    申请人:——
    公开号:US20040072371A1
    公开(公告)日:2004-04-15
    Compositions useful for labeling &bgr;-amyloid plaques and neurofibrillary tangles are provided. The compositions comprises compounds of formula (I): 1 wherein R 1 is selected from the group consisting of —C(O)-alkyl, —C(O)-alkylenyl-R 4 , —C(O)O-alkyl, —C(O)O-alkylenyl-R 4 , —C═C(CN) 2 -alkyl, —C═C(CN) 2 -alkylenyl-R 4 , 2 wherein R 4 is a radical selected from the group consisting of alkyl, substituted alkyl, aryl and substituted aryl; R 5 is a radical selected from the group consisting of —NH 2 , —OH, —SH, —NH-alkyl, —NHR 4 , —NH-alkylenyl-R 4 , —O-alkyl, —O-alkylenyl-R 4 , —S-alkyl, and —S-alkylenyl-R 4 ; R 6 is a radical selected from the group consisting of —CN, —COOH, —C(O)O-alkyl, —C(O)O-alkylenyl-R 4 , —C(O)-alkyl, —C(O)-alkylenyl-R 4 , —C(O)-halogen, —C(O)NH-alkyl, —C(O)NH-alkylenyl-R 4 and —C(O)NH 2 ; R 7 is a radical selected from the group consisting of O, NH, and S; and R 8 is N, O or S; and R 2 is selected from the group consisting of alkyl and alkylenyl-R 10 and R 3 is alkylenyl-R 10 , wherein R 10 is selected from the group consisting of —OH, —OTs, halogen, spiperone, spiperone ketal, and spiperone-3-yl, or R 2 and R 3 together form a heterocyclic ring, optionally substituted with at least one radical selected from the group consisting of alkyl, alkoxy, OH, OTs, halogen, alkyl-R 10 , carbonyl, spiperone, spiperone ketal and spiperone-3-yl, and further wherein one or more of the hydrogen, halogen or carbon atoms are optionally replaced with a radiolabel.
    提供了用于标记&bgr;-淀粉样斑块和神经原纤维缠结的组合物。该组合物包括以下化合物(I):1其中R1选自由—C(O)-烷基,—C(O)-烷基烯基-R4,—C(O)O-烷基,—C(O)O-烷基烯基-R4,—C═C(CN)2-烷基,—C═C(CN)2-烷基烯基-R4,2其中R4选自烷基,取代烷基,芳基和取代芳基中的一种基团;R5选自—NH2,—OH,—SH,—NH-烷基,—NHR4,—NH-烷基烯基-R4,—O-烷基,—O-烷基烯基-R4,—S-烷基和—S-烷基烯基-R4中的一种基团;R6选自—CN,—COOH,—C(O)O-烷基,—C(O)O-烷基烯基-R4,—C(O)-烷基,—C(O)-烷基烯基-R4,—C(O)-卤素,—C(O)NH-烷基,—C(O)NH-烷基烯基-R4和—C(O)NH2中的一种基团;R7选自O,NH和S;R8为N,O或S;R2选自烷基和烷基烯基-R10,R3为烷基烯基-R10,其中R10选自—OH,—OTs,卤素,斯皮罗隆,斯皮罗隆酮,和斯皮罗隆-3-基,或R2和R3一起形成一个杂环环,可选地取代至少一个选自烷基,烷氧基,OH,OTs,卤素,烷基-R10,羰基,斯皮罗隆,斯皮罗隆酮和斯皮罗隆-3-基的基团,进一步其中一个或多个氢,卤素或碳原子可选择用放射性标记取代。
  • Methods for labeling beta-amyloid plaques and neurofibrillary tangles
    申请人:The Regents of the University of California
    公开号:US20020022002A1
    公开(公告)日:2002-02-21
    A method for labeling &bgr;-amyloid plaques and neurofibrillary tangles in vivo and in vitro, comprises contacting a compound of formula (I): 1 with mammalian tissue. In formula (I), R 1 is selected from the group consisting of —C(O)-alkyl, —C(O)-alkylenyl-R 4 , —C(O)O-alkyl, —C(O)O-alkylenyl-R 4 , —C═C(CN) 2 -alkyl, —C═C(CN) 2 -alkylenyl-R 4 , 2 R 4 is a radical selected from the group consisting of alkyl, substituted alkyl, aryl and substituted aryl; R 5 is a radical selected from the group consisting of —NH 2 , —OH, —SH, —NH-alkyl, —NHR 4 , —NH-alkylenyl-R 4 , —O-alkyl, —O-alkylenyl-R 4 , —S-alkyl, and —S-alkylenyl-R 4 ; R 6 is a radical selected from the group consisting of —CN, —COOH, —C(O)O-alkyl, —C(O)O-alkylenyl-R 4 , —C(O)-alkyl, —C(O)-alkylenyl-R 4 , —C(O)-halogen, —C(O)NH 2 , —C(O)NH-alkyl, —C(O)NH-alkylenyl-R 4 ; R 7 is a radical selected from the group consisting of O, NH, and S; and R 8 is N, O or S. R 2 and R 3 are each independently selected from the group consisting of alkyl and alkylenyl-R 10 , wherein R 10 is selected from the group consisting of —OH, —OTs, halogen, spiperone, spiperone ketal and spiperone-3-yl. Alternatively, R 2 and R 3 together form a heterocyclic ring, optionally substituted with at least one radical selected from the group consisting of alkyl, alkoxy, OH, OTs, halogen, alkylenyl-R 10 , carbonyl, spiperone, spiperone ketal and spiperone-3-yl. In the compounds of formula (I), one or more of the hydrogen, halogen or carbon atoms can, optionally, be replaced with a radiolabel.
    一种用于体内和体外标记β淀粉样斑块和神经原纤维缠结的方法,包括将式(I)的化合物1与哺乳动物组织接触。在式(I)中,R1选自由以下组成的群体:—C(O)-烷基,—C(O)-烷基亚烷基-R4,—C(O)O-烷基,—C(O)O-烷基亚烷基-R4,—C═C(CN)2-烷基,—C═C(CN)2-烷基亚烷基-R4,2R4选自由以下组成的基团:烷基,取代烷基,芳基和取代芳基;R5选自由以下组成的基团:—NH2,—OH,—SH,—NH-烷基,—NHR4,—NH-烷基亚烷基-R4,—O-烷基,—O-烷基亚烷基-R4,—S-烷基和—S-烷基亚烷基-R4;R6选自由以下组成的基团:—CN,—COOH,—C(O)O-烷基,—C(O)O-烷基亚烷基-R4,—C(O)-烷基,—C(O)-烷基亚烷基-R4,—C(O)-卤素,—C(O)NH2,—C(O)NH-烷基,—C(O)NH-烷基亚烷基-R4;R7选自由以下组成的基团:O,NH和S;R8是N,O或S。R2和R3各自独立地选自由以下组成的群体:烷基和亚烷基-R10,其中R10选自由以下组成的群体:—OH,—OTs,卤素,spiperone,spiperone ketal和spiperone-3-yl。或者,R2和R3一起形成一个杂环,可选地用以下至少一个基团取代:烷基,烷氧基,OH,OTs,卤素,亚烷基-R10,羰基,spiperone,spiperone ketal和spiperone-3-yl。在式(I)的化合物中,一个或多个氢、卤素或碳原子可以选择性地被放射性标记取代。
  • US6274119B1
    申请人:——
    公开号:US6274119B1
    公开(公告)日:2001-08-14
  • US6660530B2
    申请人:——
    公开号:US6660530B2
    公开(公告)日:2003-12-09
查看更多